Anti-KDM3B Antibody [1A8]
HA721170
ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetKDM3B
Overview
- SupplierHUABIO
- Product NameAnti-KDM3B Antibody [1A8]
- Delivery Days Customer2
- ApplicationsFlow Cytometry, ImmunoFluorescence, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID1A8
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID51780
- Target nameKDM3B
- Target descriptionlysine demethylase 3B
- Target synonyms5qNCA, C5orf7, DIJOS, JMJD1B, NET22, lysine-specific demethylase 3B, [histone H3]-dimethyl-L-lysine(9) demethylase 3B, jmjC domain-containing histone demethylation protein 2B, jumonji domain containing 1B, jumonji domain-containing protein 1B, lysine (K)-specific demethylase 3B, nuclear protein 5qNCA
- HostRabbit
- IsotypeIgG
- Protein IDQ6ZPY7
- Protein NameLysine-specific demethylase 3B
- Scientific DescriptionHistone demethylase that specifically demethylates Lys-9 of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May have tumor suppressor activity. Its gene is located in the 5q region of the genome which is deleted in del(5q) interstitial deletion, a frequent deletion found in myeloid leukemias and myelodysplasias, suggesting that it may be a good candidate for the del(5q) tumor suppressor gene. A multitude of publications have implicated JMJD1A as a driver of tumorigenesis in a variety of different cancers. Less evidence hints at JMJD1B and JMJD1C as potential oncogenic proteins. And there is persuasive data to suggest that JMJD1B is a tumor suppressor, especially in AML, and JMJD1A and JMJD1C may also be tumor suppressive in germ cell tumors. Tissue specificity: Ubiquitous. Highly expressed in placenta, skeletal muscle, kidney, heart and liver.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116161